BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Drug Development

  NeuroVive Presents TBI Clinical Study Results at Nordic Neurotrauma Conference

  NeuroVive today announced that the company will present data from its clinical phase IIa study on TBI, Copenhagen Head Injury CHIC, at the Nordic NNC in Lund, Sweden.

  November 15, 2017

   · 

  5 min read
• Drug Development

  BioTime Presents Updated OpRegen Phase I/IIa Trial Data at AAO

  There were no treatment-related serious adverse events after 15 months.

  November 15, 2017

   · 

  4 min read
• Ampio Announces Start of Open Label Extension Study to Support Commercial Label of Repeat Administration of Ampion in Severe Osteoarthritis of the Knee

  The OLE study offers patients an opportunity to receive repeat injections of Ampion after they have completed the pivotal clinical trial.

  November 15, 2017

   · 

  3 min read
• BioMidwest

  TSI Introduces the New PortaCount Respirator Fit Tester, Providing Intelligent Fit Test Solutions

  Combining the industry’s best respirator fit test with industry-first features, the new PortaCount platform is designed to provide intelligent fit test solutions across your entire respiratory protection program.

  November 15, 2017

   · 

  1 min read
• Biotech Bay

  Leaf Healthcare Release: Analysis of 10,000 Patients Shows Leaf Patient Monitoring System Dramatically Reduces Rates of Facility-Acquired Pressure Injuries

  The impact on patient outcomes has consistently been positive.

  November 15, 2017

   · 

  3 min read
• Tru-D Release: New Study Validates Importance of Implementation and Utilization of UV Disinfection Technology

  A new study has been published regarding Tru-D and its deployment at VCU.

  November 15, 2017

   · 

  2 min read
• Drug Development

  Genisphere Reports Safety of 3DNA Nanocarrier

  Genisphere announced positive results from a non-GLP safety study evaluating dose escalation and repeated dose toxicity of the company’s 3DNA nanocarrier in Sprague Dawley rats.

  November 15, 2017

   · 

  3 min read
• Business

  National Institutes of Health Awards Grant to Numerate to Develop Compounds that Enhance Bone Integration of Orthopedic Devices

  Numerate will collaborate with researchers at Mayo Clinic on the discovery of compounds for surface coating of endoprosthetic device.

  November 15, 2017

   · 

  4 min read
• Business

  Immune Pharmaceuticals Announces Third Quarter 2017 Financial Results and Provides a Corporate Update

  The Company recorded no revenue for the three-month periods ended September 30, 2017 and 2016.

  November 15, 2017

   · 

  7 min read
• Pharm Country

  Promius Pharma Announces ZEMBRACE SymTouch (Sumatriptan Injection) 3 mg Achieves Primary Endpoint in Post-Approval Clinical Trial

  Overall, the trial found that a significantly higher proportion of subjects experienced migraine pain freedom at 2 hours postdose with ZEMBRACE SymTouch compared with placebo: 51.0% versus 30.8%,.

  November 15, 2017

   · 

  7 min read